• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Risk Factors for Fibromyalgia and Chronic Widespread Pain: A 12-question Quiz

Slideshow

SAMPLE: Based on current research, what is the prevalence of fibromyalgia in the general population? Plus 11 more questions on fibromyalgia and chronic pain.

A recent review published in the journal Pain examined 60 prospective cohort studies that showed incidence and risk factors for fibromyalgia and chronic widespread pain. Answer the 12 questions below for more insights.
Related Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
Suzetrigine Phase 3 Data Presented During "Best Abstract" Session at Anesthesiologists' Annual Meeting / image credit postop concept: ©Justlight AI/stock.adobe.com

Vertex Presents Phase 3 Data on Nonopioid Suzetrigine to Treat Acute Pain at Anesthesiologists' Annual Meeting

Grace Halsey
October 21st 2024
Article

The FDA has set a PDUFA date of January 30, 2025 for the investigational oral nonopioid therapy for acute pain, which could be a first-in-class win for Vertex.

Obesity & Pain Management: A Primary Viewpoints Podcast

Obesity & Pain Management: A Primary Viewpoints Podcast

Sydney Jennings
April 27th 2023
Podcast

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

Youth with Chronic Pain Face Greater Symptoms of Depression, Anxiety than Pain-Free Peers / Image credit: ©New Africa/AdobeStock

Youth with Chronic Pain Face Greater Symptoms of Depression, Anxiety than Pain-Free Peers

Sydney Jennings
October 2nd 2024
Article

Findings from a systematic review and meta-analysis showed 1 in 3 youth with chronic pain were diagnosed with anxiety and 1 in 8 were diagnosed with depression.

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Sydney Jennings
September 29th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

FDA Accepts Vertex NDA for Suzetrigine, Investigational Oral Nonopioid Analgesic for Acute pain / Image credit Justlight/stock.adobe.com via AI

FDA Accepts Vertex NDA for Suzetrigine, Investigational Oral Nonopioid Analgesic for Acute pain

Grace Halsey
August 15th 2024
Article

If approved the selective NaV1.8 pain signal inhibitor would reflect the first new class of pain management medication in more than 20 years.

Three Obesity-Related Comorbidities and Management Guidance for Primary Care / Image credit:©Antonio Diaz/AdobeStock

Three Obesity-Related Comorbidities and Management Guidance for Primary Care

Sydney Jennings
July 17th 2024
Article

Get details on the relationship between obesity and mental health conditions, chronic pain, and hypertension, here.

© 2024 MJH Life Sciences

All rights reserved.